Matthew K. Fust - Director at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
NMRA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew K. Fust since 9/17/2023

Holdings reported by Matthew K. Fust for Neumora Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20.1K $241K $11.98 Jun 13, 2024 Direct
Stock Option (Right to Buy) 28.6K Jun 13, 2024 Direct Common Stock

Transactions reported by Matthew K. Fust for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.